Geoff Bathje, initially supportive of Psymposia’s critiques within the psychedelic field, has grown skeptical of their recent approach. Bathje argues that Psymposia’s criticism of MAPS and Lykos lacks nuance and may perpetuate stigma and hinder drug policy reform. He believes Psymposia’s tactics and rigid views could harm efforts for a balanced, inclusive approach to psychedelic therapy.

On June 4, an FDA advisory committee overwhelmingly rejected MDMA-assisted therapy for PTSD, citing inadequate evidence and concerns over therapeutic methods. Despite this setback for Lykos Therapeutics, hope remains for conditional FDA approval in August. The outcome could significantly influence the integration of psychedelics into psychiatric treatment paradigms.

Marcelo Leite reflects on his experience at Chacruna's Psychedelic Culture 2024 conference in San Francisco. He notes the conference's goal to combine psychedelic science and Indigenous knowledge and highlights some of the notable moments at the event.

Lucid News co-founder, Ken Jordan, passed away on Sunday, May 12, 2024. Jordan was a leader in the psychedelic movement and passionately believed in the importance of accurate and accessible information about psychedelics.

The Institute for Clinical and Economic Review (ICER), is an independent non-profit research organization that evaluates the evidence on the clinical and economic value of prescription drugs, medical tests, devices, and health system delivery innovations.

In this article, Marcelo Leite outlines the major developments in psychedelic science and markets going into 2024 that are causing industry trepidation. The biggest news of January comes from MAPS and its business division, which has been rebranded as Lykos Therapeutics.

The Chacruna Institute and Sacred Plant Alliance filed this amicus brief on October 17, 2023 in support of the plaintiff church in the Iowaska Church of Healing v. United States case, to emphasize to the U.S. Court of Appeals for the D.C. Circuit why the decision in the lower court, the district court, was wrongly decided.

The United Nations has played a significant historical role in the control of psychedelic drugs worldwide. 2023's World Drug Report marks a renewed interest in psychotropic substances on the part of the international governing body.

Psychedelic Science 2023 brought together 12,000 registrants in Denver, Colorado, four times as many people as the previous conference in 2017, crowning the movement to rehabilitate psychedelics for therapeutic use against depression and other disorders. Science unveils unsuspected mechanisms of brain reconfiguration and ends decades of research bans imposed by the war on drugs, but serious obstacles remain to be overcome.

The final day of Psychedelic Science 2023 focused on celebrating the accomplishments of psychiatrist Stanislav Grof. During this celebration, Indigenous voices challenged the commodification of science in psychedelic spaces through commentary & protest, leading to reactions from some leaders in the psychedelic community, including Rick Doblin and Chacruna's Bia Labate.